B
2.18
0.00 (0.00%)
| Previous Close | 2.18 |
| Open | 2.20 |
| Volume | 13,387 |
| Avg. Volume (3M) | 7,715,601 |
| Market Cap | 40,953,044 |
| Price / Earnings (TTM) | 218.00 |
| Price / Sales | 3.91 |
| Price / Book | 5.47 |
| 52 Weeks Range |
| Profit Margin | 4.28% |
| Operating Margin (TTM) | -11.31% |
| Diluted EPS (TTM) | 0.010 |
| Quarterly Revenue Growth (YOY) | -1.00% |
| Quarterly Earnings Growth (YOY) | -36.70% |
| Total Debt/Equity (MRQ) | 74.26% |
| Current Ratio (MRQ) | 1.88 |
| Operating Cash Flow (TTM) | -1.42 M |
| Levered Free Cash Flow (TTM) | 11.22 M |
| Return on Assets (TTM) | -1.21% |
| Return on Equity (TTM) | 6.10% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Bullish | Mixed |
| Medical Care Facilities (Global) | Bullish | Mixed | |
| Stock | Basel Medical Group Ltd | - | - |
AIStockmoo Score
0.1
| Analyst Consensus | 2.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -2.0 |
| Average | 0.13 |
|
Basel Medical Group Ltd provides general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. Key revenue is generated from Singapore. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| % Held by Insiders | 67.81% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |